# Stage C2.5: Official GO / NO-GO Decision

**Role:** Independent Scientific Auditor & Medical Imaging Evaluation Specialist  
**Status:** Audit Finalized  
**Date:** October 2026  
**Project:** UTTA-Med v2 (SafeAdapt Extension)  
**Subject:** Scientific Validity of Stage C2 and Readiness for Stage D Efficient Uncertainty Gating  

---

## 1. Official Recommendation

### **DECISION: CONDITIONAL GO**

**Summary:**  
The architectural, numerical, and algorithmic implementations of the SafeAdapt v2 controller and prediction-collapse monitor are verified, deterministic, and sound. However, the Stage C2 comparative reporting contained evaluation artifacts that require explicit documentation remedies before Stage D may formally proceed.

---

## 2. Audit Findings Summary

| Audit Dimension | Finding | Assessment | Required Remedy |
| :--- | :--- | :---: | :--- |
| **Assessment Denominator** | Evaluated 320 patches out of 23,987 assessment patches (1.33% sample). | Intentional compute cap, but cannot be described as a full evaluation. | Explicitly report 320 patches as a sparse, stride-sampled exploratory subset. |
| **Metric Invariance** | Reported "Frozen Source" actually executed Stage B adaptation in the evaluation script. | Implementation artifact in `evaluate_controller_mode`. | Document True Frozen Source metrics (AUROC 0.973593) vs Stage B (0.974026) in audit records. |
| **F1 Invariance** | F1 identical to 16 decimals (`0.863248`) between True Source and Stage B. | Mathematically valid: zero threshold flips across 320 patches at $\tau=0.5$. | Record confusion matrix identity (101 TP, 23 FP, 187 TN, 9 FN). |
| **Gating Regimen Parity** | Confidence-Gated achieved identical metrics to Stage B. | True: batch confidence averaged 0.9851 (never $< 0.65$), so zero updates were skipped. | Note that gating threshold was inactive on this sample. |
| **Center-0 Slide 6 Provenance** | Slide 6 originated from Center 0 (`train` and `id_val`). | Mislabelled as an "independent validation control." | Clarify that Slide 6 is an in-distribution training-center control; Slide 15 is the true OOD negative control. |
| **Controller Soundness** | Atomic rollback, parameter projection, slide resets, and fallback verified. | Robust and completely operational. | Approved for use as Stage D safety net. |
| **Regression Tests** | Complete CPU regression suite executed (`pytest tests/ -q`). | 85 passed, 2 skipped, 0 failed. | Confirmed clean baseline. |

---

## 3. Mandatory Conditions for Stage D Progression

Stage D (Efficient Uncertainty Gating) may proceed under the following strict scientific conditions:

1. **Explicit Denominator Transparency:** All Stage D comparative reports must disclose the evaluated patch count, full WSI patch count, and sampling fraction ($N_{\mathrm{eval}} / N_{\mathrm{true}}$). No subsample shall be described as a complete WSI assessment.
2. **True Source Baseline Separation:** All comparative scripts must evaluate the frozen source model using a dedicated, non-updating inference pass (`torch.no_grad()`, `model.eval()`) without instantiating an active controller step.
3. **Control Specimen Attribution:** Center-0 Slide 6 must be designated an in-distribution negative control specimen. Only Center-1 Slide 15 may be cited as an out-of-distribution negative control.
4. **Preservation of Scientific Boundaries:**
   - No modification of frozen v1 checkpoints, tables, or raw results.
   - Zero access to Hospital 2 (Center 2) development data.
   - No claims of unconditional clinical safety or non-inferiority.

---

## 4. Sign-Off & Progression Clearance

With the three forensic audit documents established:
- [STAGE_C2_5_ASSESSMENT_INTEGRITY.md](file:///C:/Users/avina/OneDrive/Desktop/UTTA-Med/docs/v2/STAGE_C2_5_ASSESSMENT_INTEGRITY.md)
- [STAGE_C2_5_ADAPTATION_EFFECT_AUDIT.md](file:///C:/Users/avina/OneDrive/Desktop/UTTA-Med/docs/v2/STAGE_C2_5_ADAPTATION_EFFECT_AUDIT.md)
- [STAGE_C2_5_GO_NO_GO.md](file:///C:/Users/avina/OneDrive/Desktop/UTTA-Med/docs/v2/STAGE_C2_5_GO_NO_GO.md)

The scientific validity of the SafeAdapt controller is reconciled. **Conditional clearance is granted to commence Stage D.**
